GTC
Ghost Tree Capital’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.87M | Sell |
65,000
-70,000
| -52% | -$2.02M | 0.57% | 42 |
|
|
2024
Q2 | $5.18M | Buy |
135,000
+5,000
| +4% | +$192K | 1.62% | 23 |
|
|
2024
Q1 | $7.64M | Buy |
+130,000
| New | +$7.64M | 2.12% | 13 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 48 |
|
|
2023
Q3 | – | Sell |
-180,000
| Closed | -$16.4M | – | 59 |
|
|
2023
Q2 | $16.4M | Buy |
180,000
+15,380
| +9% | +$1.4M | 5.41% | 4 |
|
|
2023
Q1 | $10.9M | Sell |
164,620
-135,380
| -45% | -$8.93M | 3.21% | 5 |
|
|
2022
Q4 | $15.5M | Buy |
300,000
+25,000
| +9% | +$1.29M | 6.62% | 4 |
|
|
2022
Q3 | $18.8M | Buy |
275,000
+50,000
| +22% | +$3.42M | 5.27% | 1 |
|
|
2022
Q2 | $10.2M | Sell |
225,000
-25,000
| -10% | -$1.13M | 5.3% | 2 |
|
|
2022
Q1 | $12.7M | Sell |
250,000
-75,000
| -23% | -$3.81M | 2.76% | 3 |
|
|
2021
Q4 | $15.4M | Buy |
325,000
+125,000
| +63% | +$5.91M | 5.51% | 2 |
|
|
2021
Q3 | $6.59M | Buy |
+200,000
| New | +$6.59M | 1.93% | 16 |
|
|
2021
Q2 | – | Sell |
-225,000
| Closed | -$9.66M | – | 50 |
|
|
2021
Q1 | $9.66M | Sell |
225,000
-100,000
| -31% | -$4.29M | 2.27% | 12 |
|
|
2020
Q4 | $18.6M | Buy |
+325,000
| New | +$18.6M | 4.14% | 5 |
|
|
2020
Q1 | – | Sell |
-175,000
| Closed | -$5.36M | – | 45 |
|
|
2019
Q4 | $5.36M | Buy |
+175,000
| New | +$5.36M | 1.02% | 26 |
|
|
2018
Q4 | – | Sell |
-185,000
| Closed | -$3.29M | – | 37 |
|
|
2018
Q3 | $3.29M | Hold |
185,000
| – | – | 0.7% | 34 |
|
|
2018
Q2 | $4.07M | Buy |
+185,000
| New | +$4.07M | 1.2% | 31 |
|